Leadership is about driving change at scale and requires engaging both hearts and minds. Sally Susman, Executive Vice President and Chief Corporate Affairs Officer at Pfizer, provides insights ...

Overall, Starboard’s calculation suggests the expected revenue return on R&D and M&A investments at Pfizer is just 15% between 2023 and 2030, far below the industry peer median of 38%.

Pfizer Inc. today announced changes to its executive leadership team to further advance its aspirations to discover and develop new medicines and vaccines, with an emphasis on oncology. Under his ...

The program calls for 20 college juniors to be selected for a nine-year track to Pfizer leadership. ... Browse an unrivalled portfolio of real-time and historical market data and insights from ...

WALTHAM, MASSACHUSETTS / ACCESS Newswire / February 4, 2025 / Data4Cure today announced an ongoing multi-year partnership with Pfizer, aimed at leveraging advanced analytics and knowledge graph AI ...